Literature DB >> 2169856

Local and systemic effects of an acute inflammation on eicosanoid generation capacity of polymorphonuclear cells and macrophages.

J Mathieu1, M Tissot, D Nolibe, I Florentin, J F Kergonou, J P Giroud.   

Abstract

Acute non-specific inflammation was induced in rats by injection of isologous serum into the pleural cavity. Pleural and peritoneal cells were collected at various times after pleurisy induction and tested for production of leukotriene B4 (LTB4), prostaglandin E2 (PGE2) and prostacyclin (PGI2) after in-vitro stimulation with calcium ionophore A23187. Cells obtained by lavage of pleural and peritoneal cavities of normal rats were used as controls. Increased production of LTB4, PGE2 and PGI2 by pleural cells was observed 3 days after pleurisy induction, but with a significant depression of PGI2 release at 3 h. As the relative proportions of polymorphonuclear cells (PMN) and macrophages in the inflammatory exudate varied during the development of inflammation, these cells were examined separately for LTB4 production. PMN and macrophages contributed equally to the liberation of this mediator in normal and inflamed rats. Similar qualitative and quantitative changes in LTB4 production by pleural cells were observed, irrespective of the type of irritant used (isologous serum, dextran, carrageenan, microcrystals). In contrast, intrapleural injection of saline had no significant effect. In order to determine whether local inflammation may influence mediator release by phagocytic cells at remote sites, peritoneal cells were collected 3 or 72 after pleurisy induction. The production of LTB4, PGE2 and PGI2 was increased at 72 h. Mediator production by peritoneal macrophages was observed in both normal and inflamed rats. In conclusion, acute non-specific inflammation provoked increased arachidonic acid metabolite generation by phagocytes both locally and at a distance: this occurred more than 24 h after pleurisy resolution.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2169856      PMCID: PMC2001975     

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  20 in total

1.  The modification of the oxidative metabolism of cells derived both locally and at distance from the site of an acute inflammatory reaction.

Authors:  J Bird; M Pelletier; M Tissot; J P Giroud
Journal:  J Leukoc Biol       Date:  1985-01       Impact factor: 4.962

2.  Modification of thymo-dependent and thymo-independent antibody responses during non-specific acute inflammation.

Authors:  I Florentin; M Pelletier; J P Giroud
Journal:  Int J Immunopharmacol       Date:  1984

3.  The reactivity of neutrophils at the site of an acute inflammatory reaction as measured by chemiluminescence.

Authors:  J Bird; J P Giroud
Journal:  Agents Actions       Date:  1984-10

4.  Leukocytic functions in burn-injured patients.

Authors:  M Braquet; P Lavaud; D Dormont; R Garay; R Ducousso; J Guilbaud; M Chignard; P Borgeat; P Braquet
Journal:  Prostaglandins       Date:  1985-05

5.  Prostacyclin and thromboxanes in carrageenan-induced pleurisy in the rat.

Authors:  M Tissot; C Bonne; B Martin; M Solier; J P Giroud
Journal:  Agents Actions       Date:  1984-01

6.  Arachidonic acid metabolism among human mononuclear leukocytes. Lipoxygenase-related pathways.

Authors:  M E Goldyne; G F Burrish; P Poubelle; P Borgeat
Journal:  J Biol Chem       Date:  1984-07-25       Impact factor: 5.157

Review 7.  Regulation of the immune response by prostaglandins.

Authors:  J S Goodwin; J Ceuppens
Journal:  J Clin Immunol       Date:  1983-10       Impact factor: 8.317

8.  Leukotriene B4, polymorphonuclear leukocytes and inflammatory exudates in the rat.

Authors:  A W Ford-Hutchinson; G Brunet; P Savard; S Charleson
Journal:  Prostaglandins       Date:  1984-07

9.  Study of the evolution of acute phase reactants and of thromboxane and prostacyclin during calcium pyrophosphate-induced pleurisy in the rat.

Authors:  M Tissot; M D'Asniere; M Solier; J P Giroud; R Engler
Journal:  Agents Actions       Date:  1984-01

10.  Leukotriene B4: a mediator of vascular permeability.

Authors:  M A Bray; F M Cunningham; A W Ford-Hutchinson; M J Smith
Journal:  Br J Pharmacol       Date:  1981-03       Impact factor: 8.739

View more
  5 in total

1.  Acute non-immunological inflammation inhibits natural killer (NK) activity in the lungs and enhances metastatic development.

Authors:  I Florentin; D Nolibe; J P Giroud
Journal:  Int J Exp Pathol       Date:  1991-02       Impact factor: 1.925

2.  Blockade of proteinase-activated receptor 4 inhibits neutrophil recruitment in experimental inflammation in mice.

Authors:  Lindisley F Gomides; Onésia C O Lima; Natália A Matos; Kátia M Freitas; Janetti Nogueira Francischi; Juliana Carvalho Tavares; André Klein
Journal:  Inflamm Res       Date:  2014-08-14       Impact factor: 4.575

3.  Niacin inhibits carrageenan-induced neutrophil migration in mice.

Authors:  Raphael Gomes Ferreira; Tamires Cardoso Matsui; Lindisley Ferreira Gomides; Adriana Martins Godin; Gustavo Batista Menezes; Márcio de Matos Coelho; André Klein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-03-26       Impact factor: 3.000

4.  Schistosoma mansoni SmKI-1 serine protease inhibitor binds to elastase and impairs neutrophil function and inflammation.

Authors:  Suellen B Morais; Barbara C Figueiredo; Natan R G Assis; Debora M Alvarenga; Mariana T Q de Magalhães; Rafaela S Ferreira; Angélica T Vieira; Gustavo B Menezes; Sergio C Oliveira
Journal:  PLoS Pathog       Date:  2018-02-09       Impact factor: 6.823

Review 5.  Targeting Inflammation by Flavonoids: Novel Therapeutic Strategy for Metabolic Disorders.

Authors:  Mohammad Hosein Farzaei; Amit Kumar Singh; Ramesh Kumar; Courtney R Croley; Abhay K Pandey; Ericsson Coy-Barrera; Jayanta Kumar Patra; Gitishree Das; Rout George Kerry; Giuseppe Annunziata; Gian Carlo Tenore; Haroon Khan; Matteo Micucci; Roberta Budriesi; Saeideh Momtaz; Seyed Mohammad Nabavi; Anupam Bishayee
Journal:  Int J Mol Sci       Date:  2019-10-08       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.